Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA

Summary

This study will provide evidence on whether the use of an FDA-approved drug therapy for the treatment of chronic migraine (OnabotulinumtoxinA) shows similar efficacy for treatment of chronic headaches caused by traumatic injury to the brain (TBI) from a direct hit to the head, or a fall, or a motor vehicle accident, or some other traumatic event.

Timeline

Start

2014-05

Primary completion

2016-08

Completion

2016-08

Outcome

Outcome not reported

Stopped (Enrollment): “Study discontinued due to difficulty in enrolling eligible subjects”

Drugs

Indications